Cargando…
Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference
There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and treatment of rare ovarian cancers and identifies gaps that nee...
Autores principales: | Jang, Ji Yon Agnes, Yanaihara, Nozomu, Pujade-Lauraine, Eric, Mikami, Yoshiki, Oda, Katsutoshi, Bookman, Michael, Ledermann, Jonathan, Shimada, Muneaki, Kiyokawa, Takako, Kim, Byoung-Gie, Matsumura, Noriomi, Kaku, Tsunehisa, Kuroda, Takafumi, Nagayoshi, Yoko, Kawabata, Ayako, Iida, Yasushi, Kim, Jae-Weon, Quinn, Michael, Okamoto, Aikou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447152/ https://www.ncbi.nlm.nih.gov/pubmed/28541641 http://dx.doi.org/10.3802/jgo.2017.28.e54 |
Ejemplares similares
-
Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
por: Ledermann, Jonathan A., et al.
Publicado: (2019) -
Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
por: Pujade-Lauraine, Eric
Publicado: (2013) -
Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study
por: Yoshihara, Kosuke, et al.
Publicado: (2023) -
MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma
por: Yokomizo, Ryo, et al.
Publicado: (2019) -
MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma
por: Yanaihara, Nozomu, et al.
Publicado: (2016)